![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 23, 2011 4:39:32 PM
http://finance.yahoo.com/news/InoLife-Technologies-Inc-pz-2102357648.html?x=0&.v=1&.pf=insurance&mod=pf-insurance
That's not what INOL says in its Terms of Use and Service statement:
"Based on the information you receive, you may choose to have further genetic or medical testing done under the supervision of a physician in a medical facility or medical laboratory."
InoLife says NOTHING about a reqirement for DNA-based products to be prescribed OR interpreted by a physician. Here is a link to the INOL source:
http://www.inolifetech.com/predisposition-test.htm
Can someone please explain this discrepancy?
Apprenante
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM